| 查看: 656 | 回复: 3 | |||
| 【有奖交流】积极回复本帖子，参与交流，就有机会分得作者 木腐真菌 的 40 个金币 | |||
| 当前只显示满足指定条件的回帖，点击这里查看本话题的所有回帖 | |||
[交流]
请问大家，编辑的审稿意见怎么样？值得修稿后重投吗？
|
|||
|
Your manuscript was reviewed by several experts in the field; and we are enclosing the comments they have made. As you can see, the reviewers think that the work is of potential interest; however, significant concerns have also been voiced, which would preclude publication of the paper in its present form. We are however able to consider a revised version of the manuscript providing that you satisfy the criticisms raised in the attached comments by the reviewers and/or the Editors. Please be aware that we are not sure if a revised version will positively be evaluation for publication. Should you decide to re-submit, please include a cover letter and a point-by-point response to the referees' and Editors' comments. All comments need to be addressed; and if you do not agree with some of them, please specify the reason(s). 发自小木虫IOS客户端 |
回复此楼» 猜你喜欢
有多少人是今天查系统知道结果的？
已经有16人回复
-
基金不中，共勉
已经有3人回复
-
怎么查啊
已经有5人回复
-
范进中举一文的中心思想
已经有10人回复
-
我不理解！
已经有13人回复
-
2026年的国家社科基金项目通讯评审的新规则与新动向、新挑战
已经有9人回复
-
2026国自然函评费到账
已经有25人回复
-
2026年8月25日国自然放榜前突然收到列入评审专家邮件，有关系吗？
已经有28人回复
-
能否退出参与的面上项目解除限项
已经有26人回复
-
出来了
已经有9人回复
4楼2019-11-27 09:28:15
2楼2019-11-27 08:52:26
james-james
至尊木虫 (文坛精英)
- 应助: 633 (博士)
- 金币: 40090.5
- 红花: 117
- 沙发: 17
- 帖子: 28536
- 在线: 2480.6小时
- 虫号: 1446532
- 注册: 2011-10-17
- 专业: 药物化学
3楼2019-11-27 08:57:59
投票:
